CCRM is a leading brand that aims to accelerate the development and commercialization of regenerative medicines. With a focus on commercializing living therapies, CCRM brings together stakeholders, expertise, infrastructure, and funding to drive innovation in this field. They offer a range of products and services that support the development and scaling of cell and gene therapies and regenerative medicine technologies.

CCRM's unique translational platforms address the key bottlenecks in regenerative medicine commercialization, serving as a catalyst for bringing these life-changing technologies from the lab to real-world applications. They provide extensive expertise in 11 areas, enabling technologies, collaborative processes, and specialized infrastructure to support researchers and companies in their journey towards product development. Moreover, CCRM offers educational resources, including a blog, journal articles, and white papers, sharing valuable technical information to support the manufacturing of cell and gene therapies.

They also organize educational events such as the Till & McCulloch Meetings to promote knowledge exchange and engagement within the regenerative medicine community. With a commitment to revolutionizing healthcare, CCRM is at the forefront of advancing regenerative medicine and transforming the way we approach medical treatments